Unknown

Dataset Information

Considerations for the selection of tests for SARS-CoV-2 molecular diagnostics.


ABSTRACT: During the course of 2020, the outbreak of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) spread rapidly across the world. Clinical diagnostic testing for SARS-Cov-2 infection has relied on the real-time Reverse Transcriptase Polymerase Chain Reaction and is considered the gold standard assay. Commercial vendors and laboratories quickly mobilised to develop diagnostic tests to detect the novel coronavirus, which was fundamentally important in the pandemic response. These SARS-Cov-2 assays were developed in line with the Food Drug Administration-Emergency Use Authorization guidance. Although new tests are continuously being developed, information about SARS-CoV-2 diagnostic molecular test accuracy has been limited and at times controversial. Therefore, the analytical and clini

SUBMITTER: Erbak Yılmaz H 

PROVIDER: S-EPMC9019540 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature